FDA v. Alliance for Hippocratic Medicine
View Official PDFBelow are plain-language sections to help you understand what the Court decided in FDA v. Alliance for Hippocratic Medicine and why it matters. Quotes are taken from the syllabus (the Court’s short summary at the start of the opinion).
Summary
A short, plain-English overview of FDA v. Alliance for Hippocratic Medicine.
The Supreme Court reviewed whether the plaintiffs had standing to challenge the FDA's regulatory actions regarding mifepristone. The Court found that the plaintiffs lacked Article III standing as they could not demonstrate a concrete injury caused by the FDA's actions. The decision reversed the Fifth Circuit's ruling and remanded the case.
Holding
The single most important “bottom line” of what the Court decided in FDA v. Alliance for Hippocratic Medicine.
The Court held that plaintiffs lack Article III standing to challenge FDA's actions regarding the regulation of mifepristone.
Constitutional Concepts
These are the Constitution-related themes that appear in FDA v. Alliance for Hippocratic Medicine. Click a concept to see other cases that involve the same idea.
-
Why Standing is relevant to FDA v. Alliance for Hippocratic Medicine
The Court's decision focused on whether the plaintiffs had Article III standing to challenge the FDA's actions.
Syllabus excerpt (verbatim)Held: Plaintiffs lack Article III standing to challenge FDA's actions regarding the regulation of mifepristone.
-
Why Judicial Review is relevant to FDA v. Alliance for Hippocratic Medicine
The case involves the power of the courts to review FDA's regulatory actions.
Syllabus excerpt (verbatim)To obtain a judicial determination of what the governing law is, a plaintiff must have a 'personal stake' in the dispute.
-
Why Administrative Law is relevant to FDA v. Alliance for Hippocratic Medicine
The case involves constitutional limits on agency authority, specifically the FDA's regulatory actions.
Syllabus excerpt (verbatim)Plaintiffs are unregulated parties who seek to challenge FDA's regulation of others.
Key Quotes
Short excerpts from the syllabus in FDA v. Alliance for Hippocratic Medicine that support the summary and concepts above.
Plaintiffs lack Article III standing to challenge FDA's actions regarding the regulation of mifepristone.
Standing is 'built on a single basic idea—the idea of separation of powers.'
The 'assumption' that if these plaintiffs lack 'standing to sue, no one would have standing, is not a reason to find standing.'
